Blue announces new financing round
Paris, March 7th 2017 – Blue Industry and Science (“Blue”) raises 1 million € to boost its commercial deployment, targeting major international industrial partners. This round has been subscribed by Newfund along with business angels and the management of Blue. This new round of financing brings the total amount invested to 6M€.
Based on a breakthrough laser source, the gas analyzers from Blue offer significant improvements to the growing laser spectrometer technology: the ability to monitor hundreds of gases with one single laser source, the robustness of the measurements even in changing process environment, and a very fast application development time.
Julien Roquette, CEO of Blue, commented : « Our company has shown very strong progress in 2016 in positioning our unique technology with key partners. Our solutions help our customers address new challenges for demanding process control applications. One of our anchor customers is Sanofi, we’ve been collaborating with them since 2015 and the capabilities of our technology was found of great value for their applications. »
Anne-Sophie Nédellec, Investment Director at Newfund, commented : «Blue’s unique technology brings advanced lab capabilities directly on the production lines: that is a very key requirement of Blue’s customers. »
About Blue Industry and Science:
Blue is the world specialist of tunable lasers adapted to the detection of infinitesimal amounts of hundreds of gases, in real-time, for the monitoring of industrial processes and work atmospheres. Blue has developed dedicated solutions for customers in Oil&Gas, Energy, Food, Chemistry and Pharmaceuticals.
About Newfund :
Newfund is an early-stage cross-border entrepreneurial venture capital firm. It raised €200M from entrepreneurs and family offices. Newfund especially invested in Medtech Surgical (www.medtechsurgical.com), Infirmiers.com (www.infirmiers.com), In2bones (www.in2bones.com), Customermatrix (www.customermatrix.com) and Tageos (www.tageos.com).